Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Phalanx's CytoOneArray

Premium

Phalanx Biotech recently launched its CytoOneArray.

The Taiwanese company designed the chromosomal microarray for prenatal and postnatal detection of microdeletions and microduplications related to congenital disorders, especially developmental and intellectual delay disorders. According to Phalanx, CytoOneArray is capable of detecting 264 clinically confirmed disease regions and 41 subtelomere regions.

CEO Shengwan Lee said in a statement that CytoOneArray is the "first in a series" of chromosomal microarray products, and noted that the release occured at a "time when cytogeneticists are adopting chromosomal microarray as a first-tier clinical diagnostic test."

To design CytoOneArray, Phalanx worked with "leading cytogeneticists" in Taiwan. Following a curation process of disease regions, the company designed probes to cover 90 percent of published microdeletions and microduplications associated with developmental and intellectual delay disorders.

BioArray News discussed Phalanx's entry into the chromosomal array market earlier this year (BAN 3/13/2012)

The Scan

Alzheimer's Risk Gene Among Women

CNN reports that researchers have found that variants in MGMT contribute to Alzheimer's disease risk among women but not men.

Still Hanging Around

The Guardian writes that persistent pockets of SARS-CoV-2 in the body could contribute to long COVID.

Through a Little Spit

Enteric viruses like norovirus may also be transmitted through saliva, not just the fecal-oral route, according to New Scientist.

Nature Papers Present Method to Detect Full Transcriptome, Viruses Infecting Asgard Archaea, More

In Nature this week: VASA-seq approach to detect full transcriptome, analysis of viruses infecting Asgard archaea, and more.